Lone Pine Capital

Superinvestor

Lone Pine Capital LLC

SEC CIK: 0001061165
Manager: Stephen Mandel
Style: Growth, Hedge fund
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

FATE holding history

Fate Therapeutics Inc in every 13F filed by Lone Pine Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overview All 13F holders of FATE Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of FATE by Lone Pine Capital, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−2,199,284−100.0%	Sold out	Holders
Q3 2021	2,199,284	$130.4M	0.4%	+450,000+25.7%	Added	Holders
Q2 2021	1,749,284	$151.8M	0.5%	00.0%	Unchanged	Holders
Q1 2021	1,749,284	$144.2M	0.5%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.